Clarity Pharmaceuticals Ltd

OTCPK:CLRP.F Stock Report

Market Cap: US$1.2b

Clarity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:CLRP.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 24BuyUS$2,573,027Bank of America Corporation, Asset Management ArmCompany444,419US$5.79
23 Sep 24SellUS$1,437,241Bank of America Corporation, Asset Management ArmCompany250,293US$5.74
20 Sep 24BuyUS$32,351Merrill Lynch & Co. Inc., Banking InvestmentsCompany5,479US$5.90
20 Sep 24SellUS$1,044,856Merrill Lynch & Co. Inc., Banking InvestmentsCompany185,399US$5.64
17 Sep 24BuyUS$37,536,195Bank of America Corporation, Asset Management ArmCompany10,426,657US$3.60
17 Sep 24SellUS$28,593,837Bank of America Corporation, Asset Management ArmCompany7,362,426US$3.88
12 Sep 24BuyUS$1,689,275Merrill Lynch & Co. Inc., Banking InvestmentsCompany409,239US$4.13
03 Sep 24SellUS$1,072,183Merrill Lynch & Co. Inc., Banking InvestmentsCompany221,711US$4.84
20 May 24BuyUS$45,410Robert ThomasIndividual15,908US$2.94
29 Apr 24BuyUS$57,025Robert ThomasIndividual34,092US$1.67
29 Nov 23SellUS$256,420Charles MorganIndividual300,000US$0.85

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CLRP.F?
Owner TypeNumber of SharesOwnership Percentage
State or Government3,599,9201.12%
Private Companies35,448,46211.1%
Institutions40,196,37712.6%
Individual Insiders57,135,85817.8%
General Public183,830,84857.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.3%.


Top Shareholders

Top 25 shareholders own 42.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.66%
Christopher Roberts
18,111,280US$67.3m1.12%no data
5.22%
TM Ventures Pty Ltd.
16,699,842US$62.1m-11.1%no data
4.9%
Alan Taylor
15,693,438US$58.3m7.42%no data
4.62%
The Vanguard Group, Inc.
14,802,513US$55.0m0%no data
3.06%
Argo Investments Limited
9,802,322US$36.4m6%0.73%
2.51%
Yarrawah Pty Ltd
8,040,000US$29.9m3.03%no data
2.13%
Vantres Pty Ltd
6,812,340US$25.3m-9.02%no data
2.06%
Charles Morgan
6,600,041US$24.5m0%no data
1.89%
Matthew Harris
6,065,800US$22.5m0%no data
1.56%
Smarter Capital Pty Ltd
5,004,543US$18.6m0%no data
1.46%
Bank of America Corporation, Asset Management Arm
4,675,014US$17.4m0%no data
1.35%
Colin Biggin
4,334,085US$16.1m33.4%no data
1.22%
Kylaco Pty Ltd
3,896,280US$14.5m0%no data
1.12%
Australian Nuclear Science and Technology Organisation
3,599,920US$13.4m0%no data
1%
Guido Belgiorno-Nettis
3,210,425US$11.9m3.03%no data
0.81%
BlackRock, Inc.
2,586,748US$9.6m5.7%no data
0.36%
Robert Thomas
1,145,000US$4.3m0%no data
0.34%
Michelle Parker
1,077,710US$4.0m101%no data
0.22%
Thomas Ramdahl
720,000US$2.7m38.5%no data
0.21%
BetaShares Capital Limited
675,421US$2.5m2.36%0.01%
0.17%
Merrill Lynch & Co. Inc., Banking Investments
548,412US$2.0m0%no data
0.16%
Charles Schwab Investment Management, Inc.
518,832US$1.9m0%no data
0.12%
Portland Investment Counsel Inc.
400,235US$1.5m0%0.45%
0.11%
Norges Bank Investment Management
367,730US$1.4m0%no data
0.11%
SEI Investments Management Corporation
361,380US$1.3m255%no data